michigan semaglutide gastroparesis class action At least 3,000 patients have filed lawsuits against the companies behind GLP-1 weight loss drugs, alleging severe health risks, including blindness. NewsNation's Brooke Shafer has the story on "Morning in America." Lawsuits claiming Ozempic, other GLP-1s

Built for anyone managing a weekly or bi-weekly injection schedule including peptide therapy storage, hormone replacement therapy (HRT), testosterone replacement (TRT), GLP-1 medications (semaglutide, tirzepatide, Ozempic, Mounjaro, Zepbound), and insulin vial storage

Mimic fullness through food choices Semaglutide slows down gastric emptying, creating the sensation of being full for longer

Long-term Semaglutide use offers strong benefits, especially for weight and metabolic health

Ask your doctor before changing your dose or medication schedule

Semaglutide has a half-life of approximately 7 days, which is unusually long for an injectable drug